Literature DB >> 29462368

Dural Cells Release Factors Which Promote Cancer Cell Malignancy and Induce Immunosuppressive Markers in Bone Marrow Myeloid Cells.

Nicholas J Szerlip1,2, Alexandra Calinescu1, Eleanor Smith3, Rebecca Tagett4, Katrina L Clines4,5, Henry H Moon4,5, Russell S Taichman6, Catherine H Van Poznak7, Gregory A Clines2,5.   

Abstract

BACKGROUND: Thirty per cent of cancer patients develop spine metastases with a substantial number leading to spinal cord compression and neurological deficits. Many demonstrate a propensity toward metastasis to the posterior third of the vertebral body. The dura, the outer layer of the meninges, lies in intimate contact with the posterior border of the vertebral body and has been shown to influence adjacent bone. The effects of the dura on bone marrow and cancer cells have not been examined. Understanding the biology of spinal metastasis will provide insights into mechanisms of cancer growth and allow for new treatment strategies.
OBJECTIVE: To examine the extent to which dura influences bone marrow/tumor cell metastatic characteristics.
METHODS: Dura conditioned media (DCM) from primary dura was examined for the ability to stimulate tumor cell proliferation/invasion and to alter bone marrow cell populations. RNA sequencing of dural fibroblasts was performed to examine expression of cytokines and growth factors.
RESULTS: DCM induced a significant increase in invasion and proliferation of multiple tumor cell lines, and of patient-derived primary spinal metastatic cells. DCM also increased the proliferation of bone marrow myeloid cells, inducing expression of immunosuppressive markers. RNA sequencing of dural fibroblasts demonstrated abundant expression of cytokines and growth factors involved in cancer/immune pathways.
CONCLUSION: Factors released by primary dural cells induce proliferation of tumor cells and alter bone marrow to create a fertile environment for tumor growth. The dura therefore may play an important role in the increased incidence of metastases to adjacent bone.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29462368      PMCID: PMC7191887          DOI: 10.1093/neuros/nyx626

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  32 in total

1.  Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial.

Authors:  Roy A Patchell; Phillip A Tibbs; William F Regine; Richard Payne; Stephen Saris; Richard J Kryscio; Mohammed Mohiuddin; Byron Young
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

2.  Dura mater biology: autocrine and paracrine effects of fibroblast growth factor 2.

Authors:  Jason A Spector; Joshua A Greenwald; Stephen M Warren; Pierre J Bouletreau; Robert C Detch; Peter J Fagenholz; Francesca E Crisera; Michael T Longaker
Journal:  Plast Reconstr Surg       Date:  2002-02       Impact factor: 4.730

Review 3.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

4.  Dura mater stimulates human adipose-derived stromal cells to undergo bone formation in mouse calvarial defects.

Authors:  Benjamin Levi; Emily R Nelson; Shuli Li; Aaron W James; Jeong S Hyun; Daniel T Montoro; Min Lee; Jason P Glotzbach; George W Commons; Michael T Longaker
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

5.  Effects of sepsis on mast cells in rat dura mater: influence of L-NAME and VIP.

Authors:  F Tore; A M Reynier-Rebuffel; N Tuncel; J Callebert; P Aubineau
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 6.  'Cancer associated fibroblasts'--more than meets the eye.

Authors:  Shalom Madar; Ido Goldstein; Varda Rotter
Journal:  Trends Mol Med       Date:  2013-06-13       Impact factor: 11.951

Review 7.  Myeloid-derived suppressor cells as regulators of the immune system.

Authors:  Dmitry I Gabrilovich; Srinivas Nagaraj
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

8.  Insulin-like growth factor-1 endues monocytes with immune suppressive ability to inhibit inflammation in the intestine.

Authors:  Rong-Ti Ge; Li-Hua Mo; Ruijin Wu; Jiang-Qi Liu; Huan-Ping Zhang; Zhigang Liu; Zhanju Liu; Ping-Chang Yang
Journal:  Sci Rep       Date:  2015-01-15       Impact factor: 4.379

9.  Female mice lacking Xist RNA show partial dosage compensation and survive to term.

Authors:  Lin Yang; James E Kirby; Hongjae Sunwoo; Jeannie T Lee
Journal:  Genes Dev       Date:  2016-08-01       Impact factor: 11.361

10.  Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States.

Authors:  Rohini K Hernandez; Avanti Adhia; Sally W Wade; Emily O'Connor; Jorge Arellano; Kevin Francis; Hasmik Alvrtsyan; Ryan P Million; Alexander Liede
Journal:  Clin Epidemiol       Date:  2015-07-17       Impact factor: 4.790

View more
  2 in total

Review 1.  Bone metastasis from glioblastoma: a systematic review.

Authors:  Michael J Strong; Sravanthi Koduri; Jodi A Allison; Cecilia M Pesavento; Sebele Ogunsola; Oludotun Ogunsola; Timothy J Yee; Siri Sahib S Khalsa; Yamaan S Saadeh; Jacob R Joseph; Osama N Kashlan; Paul Park; Mark E Oppenlander; Nicholas J Szerlip
Journal:  J Neurooncol       Date:  2022-05-17       Impact factor: 4.130

2.  Dura promotes metastatic potential in prostate cancer through the CXCR2 pathway.

Authors:  Michael J Strong; Sabrina Rocco; Russell Taichman; Gregory A Clines; Nicholas J Szerlip
Journal:  J Neurooncol       Date:  2021-04-09       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.